Archive - July 2026
R1 Therapeutics forms advisory board to support advancement of AP306
AlzeCure enters collaboration agreement with QuantumCell ApS for NeuroRestore project
Novartis receives European Commission approval for Itvisma for spinal muscular atrophy
Francis Crick Institute and Medicines Discovery Catapult open applications for next KQ Labs cohort
Sofinnova reports Myricx Bio to be acquired by Novartis
Wegovy pill launches in UK as first daily oral GLP‑1 for weight management
Ferrer and Prilenia begin confirmatory study of pridopidine in Huntington’s disease
Compass Pathways reports six‑month data confirming durable profile of COMP360